The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Diphenyl(2-(naphthalen-2-yl)-4-phenyl quinolin-8-yl)phosphine oxide ID: ALA4556142
PubChem CID: 155556923
Max Phase: Preclinical
Molecular Formula: C37H26NOP
Molecular Weight: 531.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=P(c1ccccc1)(c1ccccc1)c1cccc2c(-c3ccccc3)cc(-c3ccc4ccccc4c3)nc12
Standard InChI: InChI=1S/C37H26NOP/c39-40(31-17-6-2-7-18-31,32-19-8-3-9-20-32)36-22-12-21-33-34(28-14-4-1-5-15-28)26-35(38-37(33)36)30-24-23-27-13-10-11-16-29(27)25-30/h1-26H
Standard InChI Key: XCZKXDIIXRGEQX-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 46 0 0 0 0 0 0 0 0999 V2000
6.4783 -17.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4772 -18.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1921 -18.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9086 -18.2411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1902 -17.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9049 -17.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6129 -16.9993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6127 -16.1762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8982 -15.7665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1839 -16.1800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8950 -14.9440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6103 -14.5306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1770 -13.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1819 -14.5358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3244 -17.4099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3244 -18.2361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0389 -18.6475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7537 -18.2337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7497 -17.4044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0347 -16.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7637 -17.0017 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
5.7635 -16.1766 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5202 -17.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9380 -16.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5307 -16.2779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7057 -16.2733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2883 -16.9867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7019 -17.7064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5255 -17.7075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6753 -18.0398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4316 -18.8725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0320 -19.5012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8794 -19.2915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1191 -18.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8931 -13.2944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6055 -13.7070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3170 -13.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3173 -12.4734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6002 -12.0626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8916 -12.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 1 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
11 12 2 0
12 36 1 0
35 13 1 0
13 14 2 0
14 11 1 0
9 11 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 15 1 0
1 21 1 0
21 22 2 0
21 23 1 0
21 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
23 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 23 1 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
40 35 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 531.60Molecular Weight (Monoisotopic): 531.1752AlogP: 8.36#Rotatable Bonds: 5Polar Surface Area: 29.96Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 2HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 2.53CX LogP: 9.61CX LogD: 9.61Aromatic Rings: 7Heavy Atoms: 40QED Weighted: 0.21Np Likeness Score: -0.38
References 1. Tejería A, Pérez-Pertejo Y, Reguera RM, Carbajo-Andrés R, Balaña-Fouce R, Alonso C, Martin-Encinas E, Selas A, Rubiales G, Palacios F.. (2019) Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents., 162 [PMID:30408746 ] [10.1016/j.ejmech.2018.10.065 ]